Post Marketing Surveillance on Long Drug Use of Micombi Combination Tablets in Patients With Hypertension.

Trial Profile

Post Marketing Surveillance on Long Drug Use of Micombi Combination Tablets in Patients With Hypertension.

Completed
Phase of Trial: Phase IV

Latest Information Update: 18 Jun 2014

At a glance

  • Drugs Telmisartan/hydrochlorothiazide (Primary)
  • Indications Hypertension
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Boehringer Ingelheim Pharmaceuticals
  • Most Recent Events

    • 29 Jan 2013 Primary endpoint amended as reported by ClinicalTrials.gov.
    • 02 May 2012 Actual patient number 1412 to 1434 added as reported by ClinicalTrials.gov.
    • 04 Apr 2012 Actual patient number 1412 added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top